InvestorsHub Logo
Followers 2
Posts 483
Boards Moderated 0
Alias Born 04/03/2017

Re: greenwillow post# 2950

Tuesday, 06/13/2017 7:02:33 PM

Tuesday, June 13, 2017 7:02:33 PM

Post# of 9940
I can't figure you out. Not sure if your part of the 'shoot the messenger before listening to the message' crowd.

Feb 22nd/2016

'Subject to satisfaction of remaining conditions, Revive and InMed will endeavor to enter into a definitive agreement within 30 days of the execution of the term sheet. Pursuant to the signing of a definitive agreement, InMed will grant Revive the exclusive worldwide rights to develop and commercialize the target cannabinoid(s) discovered from InMed's proprietary in silico drug/disease targeting technology. Under the term sheet, InMed will receive an upfront payment and will be eligible to receive additional milestone payments upon achievement of certain predefined pre-clinical clinical, regulatory and commercial targets, as well as royalties on commercial sales. The term sheet agreement is not binding and remains subject to further negotiation and definitive documentation. Further announcements will be made on the status of this transaction, and the details of the commercial terms.'

What did that RVV PR say?

I'm not going to bother to check sedar for the definitive agreement being filed, or not. I follow IMLFF but never thought this was real, and RVV I could care less about.

TO the person who said 'Notice the company seems to be the biggest buyer while they try and squeeze out the nervous and day traders'

Why is some of the directors market making their own stock? Seems low Energy.

I hope they progress toward EB trials in 2018. Will be watching.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News